TP63, a member of the TP53 gene family, is a nuclear marker of myoepithelial cells. Antibody against p63 is frequently used to aid in the diagnosis of prostate carcinoma, as well as in the identification of myoepithelial cells in other tissues including the breast. p63 is also a marker for squamous cell carcinoma. Recently, it was found that all p53 family members are involved in regulating the process of muscle differentiation through the retinoblastoma (RB) protein. Ablation of these p53 family functions blocks the differentiation program and promotes malignant transformation by enabling cooperating oncogenes to transform myoblasts. We therefore studied p63 expression in a number of neoplasms with myogenic differentiation. Immunohistochemical staining for p63 was performed on paraffin sections from 38 rhabdomyosarcomas, five leiomyomas, five leiomyosarcomas, five rhabdomyomas, five rhabdomyomatous Wilms tumors, three normal cardiac muscles, one medullomyoblastoma, one pleuropulmonary blastoma with rhabdomyomatous differentiation, and one teratoma with prominent rhabdomyoblasts. Each case was also stained with desmin. Unlike the nuclear staining scored in myoepithelial cells, only cytoplasmic staining for p63 was considered positive. Of 38 cases of rhabdomyosarcoma, 36 showed cytoplasmic p63 staining; 24 of these showed highlighting of cross-striations superior to that of desmin. In addition, 5/5 rhabdomyomas, 5/5 rhabdomyomatous Wilms tumors, 1/1 pleuropulmonary blastoma with rhabdomyomatous differentiation, 1/1 teratoma with atypical rhabdoblasts, and 1/1 medullomyoblastoma exhibited cytoplasmic p63 staining. Normal cardiac muscle samples (3/3) also demonstrated positive cytoplasmic staining and distinct cross-striations. Smooth muscle tumors exhibited only very focal and faint cytoplasmic staining in 5/5 leiomyomas and 4/5 leiomyosarcomas. Immunoelectron microscopic study of skeletal muscle showed p63 localization to the Z bands of sarcomeres. We conclude that p63 immunostain is a sensitive marker for skeletal muscle differentiation and highlights the cross-striations of strap cells with exceptional definition.
The p63 protein, a member of the TP53 gene family, is essential for the development of limbs, craniofacial structures, and several epithelia. p63 is expressed in the basal epithelial cells of different organs, including the breast, skin, uterine cervix, urogenital tract, and prostate. It has also been proposed as a possible marker of stem cells or reserve cells. 1 In surgical pathology, antibody to p63, solo or in cocktail combination with other immunohistochemical markers, is frequently used in the diagnosis of prostate carcinoma because normal prostatic glands are lined by p63-positive basal cells, whereas carcinomatous glands lack a basal cell layer. [2] [3] [4] p63 immunostaining is also used to support a diagnosis of squamous cell carcinoma in various sites, including the head and neck, lung, 5 uterine cervix, and anus, 6 as well as metaplastic carcinoma of the breast, 7 urothelial carcinoma, sarcomatoid carcinoma, 8 and giant cell tumor of bone. 9, 10 Recently, it was found that all p53 family members are involved in regulating muscle differentiation through the retinoblastoma (RB) protein.
The early stages of muscle differentiation, up to the expression of myogenin, can occur without the p53 family members. However, later steps involving exit from the cell cycle and activation of muscle-specific gene transcription require an active RB protein.
The p53 family members function in separate but complementary ways to produce and maintain an active RB protein. p53 is required to induce transcription of the RB gene, whereas p63 and p73 induce the cyclin-dependent kinase inhibitor p57 to maintain RB in an active, hypophosphorylated state. Loss of these p53 family functions by overexpression of DNp73 or mutations in TP53 blocks myogenic differentiation, thereby, allowing cooperating oncogenes to induce neoplastic transformation in myoblasts. Induction of cellular differentiation, therefore, may offer an explanation for the high frequency of TP53 pathway mutations seen in rhabdomyosarcoma patients. 11, 12 Rhabdomyosarcoma is the most common soft tissue sarcoma in children. 11 Given the important role of p53 family members in the development of this tumor, we hypothesized that the p63 protein might be expressed in these tumors. We further expanded our examination to include a wider variety of tumors with rhabdomyomatous differentiation, including rhabdomyomas and rhabdomyomatous Wilms tumors, as well as smooth muscle tumors and cardiac muscle.
Materials and methods

Immunohistochemistry
A total of 38 rhabdomyosarcomas from 34 patients were selected from the archives of the Department of Pathology at Indiana University School of Medicine. These included 20 embryonal (including seven spindle cell variants), five alveolar, five pleomorphic, four mixed embryonal and alveolar, two with cytodifferentiation, and two unspecified. In addition, five leiomyomas, five leiomyosarcomas, five rhabdomyomas, five rhabdomyomatous Wilms tumors, three cases of normal cardiac muscle, one medullomyoblastoma, one pleuropulmonary blastoma with rhabdomyomatous differentiation, and one teratoma with atypical rhabdoblasts were retrieved. All cases were reviewed, along with appropriate immunostains, and the diagnoses were confirmed. Formalin-fixed paraffin-embedded tissue blocks were cut in 4-mm sections and picked up onto positively charged slides. The sections were then deparaffinized and rehydrated. Antibodies against desmin (Dako, Carpinteria, CA, USA, R606, predilute) and p63 (Dako, M7247, 1:60) were then applied to sections from each case. The p63 antigen was retrieved in 1 mM EDTA buffer, pH8, by heating in a pressure cooker on high for 15 min. The primary antibody was diluted 1:60 and incubated for 30 min with the sections. Detection was accomplished using the LSAB2 method (15 min each, Dako). Desmin antigen was retrieved in Dako's 'PT Module' Tumors with skeletal muscle differentiation
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with their high pH-Target Retrieval Solution using Dako's Flex þ Mouse avidin-biotin system. Primary antibody and all subsequent incubations were 10 min each. Horseradish peroxidase conjugated to the final reagent was used to develop the brown diaminobenzidine chromagen. The immunostains were then qualitatively reviewed and assessed for the presence or absence of staining. Unlike the nuclear staining scored in myoepithelial cells, only cytoplasmic staining for p63 was considered positive. p63 staining was semiquantitatively scored for intensity on a scale of 0 to 3 þ , with 0 representing no cytoplasmic staining, 1 þ faint cytoplasmic staining, 2 þ moderate cytoplasmic staining, and 3 þ Figure 1 p63 immunostaining demonstrates well-defined cross-striations in rhabdomyosarcoma (a and b, 800 Â ), medullomyoblastoma (c, 800 Â ), rhabdomyomatous Wilms tumor (d, 800 Â ), rhabdomyoma (e, 800 Â ), and cardiac muscle (f, 800 Â ).
p63 as a muscle marker Figure 2 Comparative p63 and desmin immunohistochemistry in rhabdomyosarcoma (a, d, and g, H&E, 800 Â ). p63 immunostain (c, f and i, 800 Â ) shows distinct cross-striations, whereas desmin (b, e, and h, 800 Â ) does not. 
Results
Immunohistochemistry
Of 38 rhabdomyosarcomas, 36 (95%) showed cytoplasmic p63 staining; 24 had intense staining (3 þ ); nine moderate (2 þ ); and three faint (1 þ ) ( Table 1) . p63 clearly highlighted the cross-striations characteristic of skeletal muscle differentiation in 24 (63%) of the 38 cases (Figures 1a and b) . In comparison, cytoplasmic desmin staining was seen in 35 of 38 rhabdomyosarcomas, but only two displayed somewhat distinct cross-striations. In addition, 5/5 rhabdomyomas (three 3 þ , one 2þ , one 1þ ), 5/5 rhabdomyomatous Wilms tumors (four 3 þ , one 1 þ ), 1/1 pleuropulmonary blastoma with rhabdomyomatous differentiation (3 þ ), 1/1 teratoma with atypical rhabdoblasts (2 þ ), and 1/1 medullomyoblastoma (3 þ ) exhibited cytoplasmic p63 staining. Several of the tumor samples included adjacent normal skeletal muscle tissues that showed intense cytoplasmic immunoreactivity with prominence of the crossstriations. Normal cardiac muscle samples (3/3, two 3 þ , one 2 þ ) also demonstrated positive cytoplasmic staining and distinct cross-striations (Figures 1c-f) . Smooth muscle tumors exhibited only very focal and faint cytoplasmic staining in 5/5 leiomyomas (all 1 þ ) and 4/5 leiomyosarcomas (one 3 þ , three 2 þ , one 0).
Sections where the strap cells could be identified on H&E preparation, demonstrated parallel desmin and p63 immunoreactivity; however, p63 highlighted the cross-striations of the strap cells, with a degree of definition not seen on the desmin immunostains (Figure 2 ). Despite the fact that desmin was a poor marker for cross-striations, it showed diffuse and usually intense immunoreactivity in most cases (Table 1) .
Immunoelectron Microscopy
Skeletal muscle sections displayed p63 localization primarily to the Z lines of the sarcomeres (Figure 3 ).
Discussion
p63 immunostain is a sensitive marker for skeletal and cardiac muscle differentiation, and highlights the cross-striations of strap cells with exceptional definition, much superior to desmin. The high frequency of distinct cross-striations on immunohistochemistry, in conjunction with our immunoelectron microscopy study supports that p63 localizes to the Z lines of skeletal and cardiac muscle. This explains why smooth muscle, which lacks cross-striations and Z lines, does not stain as intensely with p63. Desmin has been reported to be concentrated in the bundles of intermediate filaments connecting Z lines to adjacent myofibrils. In addition to being present between myofibrils, desmin filaments are also found within myofibrils, which can explain its more diffuse While, in this study, only cytoplasmic staining was the subject of our analysis, we did observe nuclear staining in a small proportion of tumors. The significance of this nuclear positivity is unclear and will require further studies to elucidate.
p63 is a widely available and frequently used antibody, with many applications in general surgical pathology laboratories. We propose an additional application for p63 as a potential marker for striated muscle differentiation. It may be used in conjunction with the current skeletal muscle markers, desmin, myogenin, and myf-1. p63 may also be, especially useful in distinguishing skeletal muscle tumors from smooth muscle tumors. For example, many paratesticular rhabdomyosarcomas display spindle cell morphology, and leiomyosarcoma may enter into the differential diagnosis in this situation. Desmin stains both skeletal and smooth muscle, and therefore cannot be used to distinguish the two. However, p63 could potentially be used to aid in this differential diagnosis, as it may highlight cross-striations not seen with desmin immunohistochemistry ( Figure 4 ).
Our findings of p63 expression in skeletal muscle and tumors with skeletal muscle differentiation lend support to recent reports linking the p53 family of proteins to myogenic differentiation and rhabdomyosarcoma development.
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Whether or not the p63 immunostain becomes a highly used marker for skeletal muscle differentiation remains to be seen.
